期刊文献+

妊娠期妇女外阴阴道念珠菌病的病原学和治疗研究 被引量:21

Pathogenic and treatment study on vulvovaginal candidiasis in pregnancy
原文传递
导出
摘要 目的 调查孕妇外阴阴道念珠菌病 (vulvovaginalcandidiasis,VVC)的发病率 ,对检出的VVC进行病原学和治疗研究。 方法 连续对产科门诊 10 0 0例孕妇进行VVC发病情况调查。对分离的念珠菌进行体外抗真菌药物敏感试验。对 6 6例VVC患者应用咪康唑栓治疗 ,4 0 0mg/d ,6d为一疗程。 结果 孕妇VVC的发病率为 12 .7% (12 7/ 10 0 0 )。 37.4 % (374 / 10 0 0 )的孕妇以往有VVC病史 ,0 .6 %的孕妇为复发性VVC。 12 7例VVC中 ,白念珠菌、光滑念珠菌、热带念珠菌和克柔念珠菌分别占 87.1%、9.9%、1.5 %和 1.5 %。有 4例患者同时感染 2种念珠菌。 114株白念珠菌对咪康唑、克霉唑、氟康唑、伊曲康唑、制霉菌素耐药率依次为 10 .5 %、2 .6 %、6 .1%、7.9%和 0。 13株光滑念珠菌对咪康唑和制霉菌素均敏感 ,对克霉唑、伊曲康唑和氟康唑均敏感或剂量依赖敏感。应用咪康唑栓治疗的患者在治疗完成后 1~ 2周及 4~ 6周的病原学治愈率分别为 84 .8%和 80 .3%。 结论 VVC是孕妇的常见病 ,白念珠菌仍然是主要致病菌 ,其次为光滑念珠菌。常用抗真菌药物对引起VVC的念珠菌存在不同程度的耐药率 ,应用咪康唑栓治疗孕妇VVC效果满意。 Objective To determine the prevalence of vulvovaginal candidiasis(VVC) in pregnant women,to test its antifungal susceptibility to miconazole,clotrimazole,fluconazole, itrocona- zole,and nystatin and to treat VVC with miconazole in pregnancy. Methods Vaginal swabs were collected from unselected pregnant women in prenatal clinic. The antifungal susceptibility of 131 strains of Candidas to miconazole,clotrimazole,fluconazole,itroconazole,and nystatin were detected by Neo-Sensitabs susceptibility testing. 66 cases of VVC were treated with 6 day-course of miconazole(400 mg/d). Results The prevalence of VVC in pregnant women was 12.7%(127/1000). 37.4%(374/1000) had previous VVC. 0.6%(6/1000)of women were recurrent VVC(RVVC),which occupied 4.7%(6/127) of VVC. C. albicans was the most frequently(87.1%) isolated pathogen followed by C. glabrata (9.9%) ,C. tropicalis(1.5%),and C. krsei(1.5%). The resistant rate of C. albicans to miconazole,clotrimazole,fluconazole,itroconazole,and nystatin was 10.5%、2.6%、 6.1%、 7.9%,and 0. All 13 strains of C. glabrata was susceptible to miconazole,nystatin and susceptible or susceptible-dependent-upon-dose (SDD) to clotrimazole,fluconazole,and itroconazole. The mycological cure rate of miconazole on day 7~14 and day 28~42 was 84.8%(56/66 cases) and 80.3% (53/66 cases). Conclusions VVC is very common in pregnancy. C. albicans is the predominant Candida species in VVC and has some resistance to miconazole,clotrimazole,fluconazole,itroconazole,and nystatin. Miconazole therapy is effective on VVC treatment in pregnant women. Non-effective treatment might be associated with Candidas resistance.
出处 《中华围产医学杂志》 CAS 2004年第4期220-222,共3页 Chinese Journal of Perinatal Medicine
关键词 妊娠期 外阴阴道念珠菌病 病原学 治疗 Pregnancy complications,infectious Candidiasis, vulvovaginal Prevalence Antifungal agents Miconazole
  • 相关文献

参考文献8

  • 1符玉良,黄以宁,张维森,张秀兴,刘岩平,何桂荷,武秋林,肖燕青,梁玉屏,邓艳香,温素玲.孕妇性传播疾病高危因素评分系统模式的建立[J].中华医学杂志,1997,77(2):87-90. 被引量:14
  • 2唐振华,陆庭嫣,潘卫民.真菌性阴道炎的病原菌特点及药敏分析[J].上海医学检验杂志,2002,17(3):173-174. 被引量:27
  • 3Cotch MF,Hillier SL,Gibbs RS,et al.Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy.Vaginal infection and prematurity study group. Am J Obstet Gynecol,1998,178:374-380.
  • 4Meis PJ, Goldenberg RL, Mercer B, et al. The preterm prediction study:significance of vaginal infections.National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol,1995,173:1231-1235.
  • 5Kamara P, Hylton-Kong T, Brathwaite A, et al. Vaginal infections in pregnant women in Jamaica:prevalence and risk factors.Int J STD AIDS,2000,11:516-520.
  • 6Vidotto V, Ochoa LG, Ponce LM, et al. Vaginal yeast flora of pregnant women in the Cusco region of Peru.Mycoses,1992,35:229-234.
  • 7Sobel JD, Zervos M, Reed BD, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complited candida vaginitis: Clinical implications.Antimicrob Agents Chemother,2003,47:34-38.
  • 8CDC. Sexually transmitted diseases treatment guideline. MMWR,2002,51:No RR-6.

二级参考文献1

  • 1王端礼.要重视真菌检验工作[J].中华医学检验杂志,1996,19(5):263-263.

共引文献39

同被引文献155

引证文献21

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部